Raman spectroscopy
Keywords:
From August 28 to 30, 2024, the 18th Sullivan China Growth, Innovation & Leadership Summit and the 3rd New Investment Conference were held in Shanghai. This year’s conference is themed “Unite New Forces, Achieve Quality-Driven Future,” aiming to bring together the wisdom and strength of global industry leaders, academics, research institutions, investors, and media to jointly explore new growth drivers, new markets, and new development paths for China’s economy in the new era.
On the afternoon of December 14, Jin Nengming, Secretary of the Party Committee of China Pharmaceutical University, visited Nanjing Nuoyuan Medical Device Co., Ltd., a company founded by Cai Huiming, Chairman and alumnus of the Class of 1981. Accompanying him on the visit and exchange were several prominent alumni from the Class of 1981, including Tao Desheng, Vice Chairman of Lizhu Pharmaceutical Group; Sun Feng, Chairman of Shanghai Kangcheng Investment Management Co., Ltd.; and Zhang Yu, Chairman of Nanjing Yikang Pharmaceutical Co., Ltd., also an alumnus of the Class of 1981 based in Nanjing.
Internationally, medical endoscopes have undergone more than 200 years of development, going through three major stages: the initial stage, during which physicians began observing patients’ internal tissues and organs; the development stage, marked by the need to meet ever-changing clinical demands; and the optimization stage, aimed at satisfying increasingly diverse and growing clinical needs. However, domestically produced medical endoscopes started relatively late, with a development history of just over 30 years. Yet, alongside the rise of China as a global power, these endoscopes have made remarkable progress. Many Chinese companies have achieved breakthroughs in both quality and quantity in certain specialized segments of the medical endoscope market.
[Good News] Nuoyuan Medical Wins First Prize from the China Invention Association
Recently, the China Invention Association [National Science and Technology Award Certificate No. 0123] awarded the highest prize—the First Prize—of the China Invention Association’s “Invention and Entrepreneurship Award for Innovation” to two organizations and their respective leaders: Professor Zhang Chenping, head of the Ninth People’s Hospital of Shanghai Jiao Tong University, and Chairman Cai Huiming, head of Nanjing Nuoyuan Medical Device Co., Ltd. This award recognizes their outstanding achievements in “the integration and innovation of diagnostic and therapeutic approaches for head and neck malignant tumors.”
Latest product
Latest News